from sales and services 24.49 31.85 (7.36) (23.11%) 22.37 2.12 9.48% 69.46 87.80 (18.34) (20.89%) Other income 3.09 2.67 0.42 15.73% 2.98 0.11 3.69% 9.21 5.47 3.74 68.37% Selling expenses 8.34 6.89 1.45
on 12 underlying fundamental signals including inventories, accounts receivable, capital expenditures, research and development expenses, gross margin, selling and administrative expenses, provision
, public spending excluding transfers also contracted in both current and capital expenditures partly due to the delay of FY2020 budget. Exports for 1Q20 grew slightly at 0.9% compared to the same period
and capital expenditures partly due to the delay of FY2020 budget. Exports for the first 2 months of 2020 contracted at 0.8% compared to the same period last year. When excluding exports of gold, value
Advertising Association Thailand (DAAT) recorded THB 9,477mn of advertising expenditures in 2016 and it is expected to grow by 24% in 2017 mainly driven by the acceleration of internet access and the ubiquity
increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling
will be used to fund the repurchase of the existing notes and to finance the Group’s general corporate purposes, including, but not limited to, working capital requirements, capital expenditures, funding
117.79% Selling expenses 7.06 5.97 1.09 18.26% 6.15 0.91 14.80% 13.22 12.40 0.82 6.61% Administrative expenses 25.46 20.22 5.24 25.91% 24.96 0.50 2.00% 50.42 39.46 10.96 27.77% Net profit before finance
(51.5%) Operating expenses (716.5) (581.5) 23.2% (937.8) (23.6%) Selling and administrative expenses1 (743.8) (700.0) 6.3% (1,054.8) (29.5%) EBITDA 33.1 131.6 (74.9%) 2,116.5 (98.4%) Finance cost (281.2
expenses as a result of Company’s response plan to COVID-19. EBITDA margin fell to -17.7% (2Q 2019; 22.3%) • Reported net loss of THB 1,213mn, from the EBITDA shortfall as well as higher share of loss from